Agios Pharmaceuticals: Indication Stacking Is Creating A Commercial Flywheel (NASDAQ:AGIO)
· seekingalpha.com
Agios is leveraging mitapivat across PK deficiency, thalassemia, and sickle cell disease to build a rare disease franchise. Read more on AGIO stock here.
In my view, the market appears focused on Agios Pharmaceuticals, Inc.'s ( AGIO ) continued net losses, as well as the discontinuation of tebapivat development a...